$105.28
+2.88 (+2.81%)
Performance
1D
—
1W
—
1M
—
3M
+2.22%
6M
+9.49%
1Y
+42.99%
YTD
+4.40%
Open$103.19
Previous Close$102.40
Day High$107.52
Day Low$102.26
52W High$113.02
52W Low$63.56
Volume—
Avg Volume536.5K
Market Cap8.09B
P/E Ratio—
EPS$-5.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$103.76
Above
SMA 200
$88.57
Above
RSI (14)
53.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
-68.4% upside
Current
$105.28
$105.28
Target
$33.28
$33.28
$20.12
$33.28 avg
$44.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.56B | 1.45B | 1.21B |
| Net Income | -302,764,100 | -377,638,036 | -264,320,064 |
| Profit Margin | -19.4% | -26.0% | -21.8% |
| EBITDA | -533,448,597 | -500,050,490 | -459,692,337 |
| Free Cash Flow | -391,442,676 | -279,670,611 | -274,115,194 |
| Rev Growth | +10.6% | +5.5% | +20.0% |
| Debt/Equity | 0.68 | 0.65 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |